Tyler Nasiedlak is a registered patent attorney and principal of Schwegman Lundberg & Woessner. His practice is focused on representing companies and investors on intellectual property and transactional matters, including patent portfolio strategy and development, freedom-to-operate and patent landscaping studies, due diligence and counseling in connection with acquisitions and divestitures, patent validity and infringement opinions, licensing and other technology transactions, patent post-grant proceedings, and patent enforcement and litigation strategies.

Prior to joining Schwegman, Tyler worked in the medical device space for nearly twelve years at Boston Scientific Corporation and Guidant Corporation. While at BSC/Guidant, he served as Vice President and General Counsel for its cardiac rhythm management business where he oversaw all aspects of the group’s legal operations and served as Vice President and Chief Patent Counsel for its cardiac rhythm management and cardiovascular businesses where he was responsible for counseling senior management on patent matters, overseeing patent litigation, and driving intellectual property strategy. During his time at BSC/Guidant, Tyler extensively advised executives on freedom-to-operate issues, patent post-grant proceedings and litigation matters, technology transactions, and negotiated and helped evaluate business development deals on a wide variety of medical devices. Prior to working at BSC/Guidant, Tyler was a patent attorney with the firm of Merchant & Gould.